Panel: Gene Therapy: The Outlook in 2018Featured video

admin
Sorry, only registred users can create playlists.

Published by Admin in FKN News Sci

24 Views

Description

Speakers:
Martha Rook, Head of Gene Editing and Novel Modalities, MilliporeSigma (chair)
Bill Lundberg, CSO, CRISPR Therapeutics
Sandy Macrae, President and CEO, Sangamo Therapeutics
Geoff Nichol, SVP, Global Clinical Development and CMO, BioMarin Pharmaceutical
Amber Salzman, President and CEO, Adverum Biotechnologies
Deepak Srivastava, President, Gladstone Institutes; Professor, UC San Francisco

Post your comment

Be the first to comment